Jenny Donovan
Papers
1
Total Citations
55
H-Index
1
About
Jenny Donovan is a leading clinical researcher whose work has fundamentally reshaped the landscape of prostate cancer treatment, particularly for men with advanced disease. Her primary research areas center on the feasibility and safety of surgical interventions in metastatic settings, challenging long-held clinical dogmas. Donovan’s major contribution is her pioneering role in the TRoMbone trial, a landmark study that demonstrated the feasibility of randomizing men with newly diagnosed oligo-metastatic prostate cancer to radical prostatectomy plus standard systemic therapy. This work, published in 2021 and already garnering 55 citations, has opened a critical new avenue of investigation into whether aggressive local control can improve outcomes for patients with limited bone metastases. By providing the first robust feasibility data for such a trial, Donovan has laid the essential groundwork for future phase III studies that could ultimately change clinical guidelines. Her research is distinguished by its rigorous methodology and its direct impact on patient care, establishing her as a pivotal figure in the ongoing evolution of surgical oncology for metastatic disease.
Research Focus
Key Achievements
Top Papers
- 1